We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRN
776
Chiron Real Estate Inc
XRN
$477M
$136K 0.03%
+3,119
New +$150K
TG icon
777
Tredegar Corp
TG
$310M
$136K 0.03%
20,872
+10,597
+103% +$51.6K
HTLD icon
778
Heartland Express
HTLD
$956M
$136K 0.03%
+11,354
New +$144K
WW
779
DELISTED
WW International
WW
$135K 0.03%
+73,141
New +$291K
AEHR icon
780
Aehr Test Systems
AEHR
$3.36B
$135K 0.03%
+10,859
New +$181K
CRCT icon
781
Cricut
CRCT
$1.22B
$129K 0.03%
+27,018
New +$144K
OLMA icon
782
Olema Pharmaceuticals
OLMA
$1.05B
$127K 0.02%
+11,212
New +$145K
HTBK
783
DELISTED
Heritage Commerce
HTBK
$124K 0.02%
+14,469
New +$126K
CVGI icon
784
Commercial Vehicle Group
CVGI
$147M
$115K 0.02%
+17,952
New +$116K
AUPH icon
785
Aurinia Pharmaceuticals
AUPH
$2.11B
$115K 0.02%
+23,017
New +$156K
GDOT icon
786
Green Dot
GDOT
$745M
$113K 0.02%
12,158
-2,542
-17% -$22.4K
ACCD
787
DELISTED
Accolade Inc
ACCD
$113K 0.02%
+10,764
New +$122K
HCAT icon
788
Health Catalyst
HCAT
$128M
$110K 0.02%
14,626
+3,633
+33% +$33.2K
ARKO icon
789
ARKO Corp
ARKO
$635M
$110K 0.02%
+19,223
New +$140K
WGS icon
790
GeneDx Holdings
WGS
$2.3B
$108K 0.02%
+11,822
New +$71K
AVPT icon
791
AvePoint
AVPT
$2.71B
$102K 0.02%
+12,908
New +$102K
SEI
792
Solaris Energy Infrastructure
SEI
$3.82B
$102K 0.02%
11,743
-8,473
-42% -$66.5K
ONL
793
Orion Office REIT
ONL
$160M
$102K 0.02%
+28,965
New +$130K
FLL icon
794
Full House Resorts
FLL
$89M
$99.8K 0.02%
17,918
+5,848
+48% +$28.9K
OOMA icon
795
Ooma
OOMA
$604M
$99.2K 0.02%
+11,633
New +$116K
APPS icon
796
Digital Turbine
APPS
$1.74B
$96.6K 0.02%
+36,886
New +$156K
AGS
797
DELISTED
PlayAGS
AGS
$91.4K 0.02%
+10,177
New +$88.9K
TNGX icon
798
Tango Therapeutics
TNGX
$4.41B
$91K 0.02%
+11,467
New +$123K
GNL icon
799
Global Net Lease
GNL
$1.95B
$86.9K 0.02%
+11,184
New +$91.8K
SIRI icon
800
SiriusXM
SIRI
$10.1B
$86.8K 0.02%
+2,237
New +$106K
30 31
32
33 34

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.